Trump targeted pharmacy benefit managers for increasing drug prices. He pledged to remove them from the system. This caused share drops for CVS, Cigna, and UnitedHealth. These companies manage drug costs for health plans. They negotiate with pharmacies and drug manufacturers. They also face investigations over drug pricing practices.
